Recombinant Xenopus laevis Corticoliberin (crh)

Shipped with Ice Packs
In Stock

Description

Definition and Nomenclature

Recombinant Xenopus laevis corticoliberin (CRH) refers to a synthetic form of the corticotropin-releasing hormone (CRH) produced via recombinant DNA technology. CRH, also termed corticoliberin, is a 41-amino acid neuropeptide critical for regulating stress responses, endocrine axes, and life transitions in vertebrates . The recombinant form is engineered to replicate the native Xenopus CRH (xCRH), which shares structural and functional homology with mammalian CRH but exhibits unique receptor-binding profiles .

Primary Structure

xCRH is an α-helical peptide with a C-terminal amide group, structurally conserved across vertebrates . Key differences from mammalian CRH include variations in receptor selectivity (e.g., higher affinity for urocortin and sauvagine in Xenopus CRF-R2 compared to mammalian counterparts) .

FeatureXenopus laevis CRHMammalian CRH
Length41 amino acids41 amino acids
C-terminal AmidationPresentPresent
Receptor SelectivityCRF-R2 > CRF-R1CRF-R1 > CRF-R2
Key LigandsUrocortin, SauvagineCRH, Urocortin

Data synthesized from

Functional Roles

xCRH regulates:

  • Stress response: Activates the hypothalamic-pituitary-interrenal (HPI) axis, stimulating corticosterone secretion .

  • Metamorphosis: Modulates thyroid hormone (T4) and interrenal hormone release, influencing developmental transitions in tadpoles .

  • Energy balance: Suppresses food intake in juveniles, mirroring conserved roles in mammals .

Synthesis and Production

Recombinant xCRH is typically produced via bacterial or yeast expression systems. The process involves:

  1. Cloning: Insertion of the xcrh gene into a plasmid vector.

  2. Expression: Induction of protein synthesis in E. coli or Pichia pastoris.

  3. Purification: Use of chromatography (e.g., reversed-phase HPLC) to isolate the peptide .

Challenges:

  • CRH-Binding Protein (CRH-BP) Interference: Native Xenopus brain expresses high levels of CRH-BP, which binds xCRH with nanomolar affinity (K<sub>i</sub> = 1.08 nM) . Acid extraction is required to minimize interference during purification .

Receptor Subtypes

Two CRH receptors are identified in Xenopus:

ReceptorLigand Affinity (K<sub>D</sub>, nM)Function
CRF-R1Human/rat CRH: 1.1 nM; Sauvagine: 51.4 nMStress response, ACTH release
CRF-R2Urocortin: 0.54 nM; Sauvagine: 0.5 nMRegulatory feedback, energy balance

Data from

Unique Pharmacological Features

  • CRF-R1 Selectivity: xCRF-R1 exhibits 10–22-fold higher affinity for urocortin and human CRH compared to ovine CRH, unlike mammalian CRF-R1 .

  • CRH-BP Modulation: CRH-BP in Xenopus binds xCRH with high affinity, acting as a negative regulator of CRH signaling .

Experimental Models

  • Metamorphosis Studies: Used to analyze thyroid and interrenal axis regulation during tadpole development .

  • Food Intake Regulation: ICV injections of xCRH reduce feeding in juveniles, linking CRH to energy homeostasis .

Tissue Expression

TissueCRH-BP mRNA ExpressionFunction
BrainHigh (cerebrum, hypothalamus)Stress signaling, neuroendocrine regulation
PituitaryModerateACTH secretion modulation
TailUpregulated during metamorphosisTissue remodeling coordination

Data from

Evolutionary Insights

  • Conserved Roles: CRH’s involvement in stress and metamorphosis is conserved across amphibians and teleosts, highlighting its ancestral function in vertebrate life transitions .

  • Gene Duplication: Teleosts exhibit crh1a and crh1b paralogs, with crh1b retained in Xenopus for corticotropic axis regulation .

Challenges and Future Directions

  • Production Scalability: Recombinant xCRH synthesis remains limited by CRH-BP interference and low yields in heterologous systems .

  • Therapeutic Potential: Studies on CRH-BP regulation in Xenopus may inform strategies to modulate stress-related disorders in mammals .

Product Specs

Form
Lyophilized powder. We will ship the in-stock format preferentially. If you have specific format requirements, please note them when ordering.
Lead Time
Delivery times vary by purchase method and location. Consult your local distributor for specifics. All proteins ship with standard blue ice packs. Request dry ice in advance (extra fees apply).
Notes
Avoid repeated freezing and thawing. Working aliquots are stable at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening. Reconstitute in sterile deionized water to 0.1-1.0 mg/mL. Add 5-50% glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. Our default final glycerol concentration is 50%.
Shelf Life
Shelf life depends on storage conditions, buffer components, temperature, and protein stability. Liquid form is generally stable for 6 months at -20°C/-80°C. Lyophilized form is generally stable for 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
The tag type is determined during manufacturing. If you require a specific tag, please inform us and we will prioritize its development.
Synonyms
crhCorticoliberin; Corticotropin-releasing factor; CRF; Corticotropin-releasing hormone
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
120-160
Protein Length
Cytoplasmic domain
Purity
>85% (SDS-PAGE)
Species
Xenopus laevis (African clawed frog)
Target Names
crh
Target Protein Sequence
A EEPPISLDLT FHLLREVLEM ARAEQIAQQA HSNRKLMDII
Uniprot No.

Target Background

Function
This hypothalamic hormone regulates corticotropin release from the pituitary gland.
Database Links

KEGG: xla:100337609

UniGene: Xl.85742

Protein Families
Sauvagine/corticotropin-releasing factor/urotensin I family
Subcellular Location
Secreted.

Q&A

What is Xenopus laevis CRH and what are its main functions in amphibian physiology?

Xenopus laevis corticoliberin is a stress neuropeptide expressed in various tissues including the tadpole tail. Research has demonstrated that it is upregulated by environmental stressors and provides cytoprotective effects . CRH functions primarily through CRF receptors, particularly the CRF type 1 receptor (CRF-R1) in tadpole tissue .

In Xenopus, CRH has several documented functions:

  • Slows spontaneous tail regression in explant culture

  • Reduces caspase 3/7 activity, suggesting anti-apoptotic properties

  • Increases [³H]thymidine incorporation in XLT-15 cells (a tail muscle-derived cell line), indicating a role in cell proliferation

  • Responds dynamically to environmental stressors like hypoxia, which increases CRH expression

The activity of CRH is modulated by CRH binding protein (CRH-BP), which is regulated by hormones and environmental stressors. During metamorphosis, CRH-BP is strongly upregulated in the tail, suggesting involvement in the programmed cell death that occurs during this developmental transition .

How do CRH receptors in Xenopus laevis differ from mammalian CRH receptors?

Xenopus laevis possesses two distinct CRH receptors that show significant structural and functional differences from their mammalian counterparts:

Xenopus CRF-R1 (xCRF-R1):

  • Consists of 415 amino acids with approximately 80% identity to mammalian CRF-R1

  • Unlike mammalian CRF-R1, which is non-selective for CRF ligands, xCRF-R1 shows remarkable ligand selectivity

  • Binds urotensin I, urocortin, human/rat CRF, and Xenopus CRF with 10-22 fold higher affinity than ovine CRF and sauvagine

  • Shows EC₅₀ values of 39.7 nM for sauvagine compared to 1.1 nM for human/rat CRF or Xenopus CRF in cAMP production assays

Xenopus CRF-R2 (xCRF-R2):

  • Consists of 413 amino acids with approximately 81% identity to the α-variant of mammalian CRF-R2

  • No evidence for the β-variant of CRF-R2 in Xenopus laevis

  • Shows higher binding affinity for urotensin I, urocortin, and sauvagine than for human/rat CRF, Xenopus CRF, and ovine CRF

What is the role of CRH in Xenopus tadpole development?

Xenopus tadpole development involves complex interactions between thyroid hormone (T3) and CRH signaling. Before metamorphosis, the tadpole tail functions as an essential locomotory organ, and CRH plays a critical role in tail maintenance .

CRH's developmental functions include:

  • Acting as a cytoprotective agent in tadpole tail before metamorphosis

  • Slowing spontaneous tail regression in explant culture

  • Reducing caspase 3/7 activity, indicating an anti-apoptotic effect

  • Increasing cell proliferation, as shown by enhanced [³H]thymidine incorporation in tail-derived cells

During metamorphosis, which is primarily driven by thyroid hormone (T3), tadpoles lose their tails through programmed cell death. CRH-BP is strongly upregulated in the tail during spontaneous or T3-induced metamorphosis, suggesting a regulatory role in this process . Research has shown that overexpression of CRH-BP in vivo accelerates the loss of tail muscle cells during spontaneous metamorphosis, indicating it modulates CRH bioactivity .

What experimental approaches are effective for studying CRH receptor pharmacology in Xenopus systems?

Based on published methodologies, several approaches have proven effective for studying Xenopus CRH receptor pharmacology:

Receptor Binding Assays:

  • Membrane isolation from transfected cells expressing various receptors

  • Scatchard analysis with 50-100 μg of protein to determine binding parameters

  • Competitive binding assays using various CRF analogs (human/rat CRF, Xenopus CRF, ovine CRF, sauvagine, urotensin I, urocortin)

Functional Assays:

  • cAMP production assays in transfected cells (typically HEK 293 cells)

  • Stimulation protocols of 30 min at 37°C with peptides of interest

  • Statistical analysis by two-way ANOVA with post hoc analysis using the Dunnett test

Cell Expression Systems:

  • XLT-15 cells (Xenopus tail muscle-derived cell line) expressing endogenous CRF receptors

  • HEK 293 cells stably transfected with Xenopus CRF receptors (wild-type, chimeric, or mutant)

Receptor Characterization:

  • Creation of chimeric receptors to map functional domains

  • Site-directed mutagenesis to identify key amino acids

  • Expression of mutant receptors to assess ligand binding and signal transduction

How can researchers determine the key structural elements responsible for the ligand selectivity of Xenopus CRF-R1?

Research has identified the structural basis for the unique ligand selectivity of Xenopus CRF-R1 through systematic experimental approaches:

Chimeric Receptor Studies:
Through creation of chimeric receptors between human and Xenopus CRF-R1, researchers mapped the ligand-selective domain to the N-terminal extracellular region (EC1), specifically to amino acids 70-89 .

Point Mutation Analysis:
Five critical amino acids were identified as responsible for the ligand selectivity:

PositionxCRF-R1hCRF-R1
76GlnArg
81GlyAsn
83ValGly
88HisLeu
89LeuAla

Experimental Confirmation:

  • Replacement of all five amino acids in hCRF-R1 with the corresponding xCRF-R1 residues created a receptor with ~30-fold higher affinity for human/rat CRF than for sauvagine

  • Mutation of just three amino acids (positions 76, 81, and 83) resulted in a receptor with ~11-fold higher affinity for human/rat CRF compared to ovine CRF or sauvagine

  • Mutagenesis of only two of these amino acids did not affect ligand selectivity, demonstrating the requirement for multiple residue changes

This methodological approach combining chimeric constructs with targeted mutations provides a blueprint for determining structure-function relationships in other peptide hormone receptors.

What considerations are important when comparing the effects of different CRH analogs on Xenopus CRF receptors?

When comparing the effects of different CRH analogs on Xenopus CRF receptors, several experimental considerations must be addressed:

Temperature Conditions:

  • Xenopus laevis is normally maintained at room temperature

  • cAMP stimulations are often carried out at 37°C, while binding assays are typically performed at room temperature

  • These temperature differences may affect receptor folding and ligand-receptor interactions

Peptide Stability and Half-life:

  • Different CRF analogs have different stability in experimental conditions

  • For example, ovine CRF has been observed to have a longer half-life than other analogs, which can affect functional assays

  • This difference may explain why ovine CRF was a more potent stimulator of cAMP production than sauvagine in some experiments, despite similar binding affinities

Receptor Expression Systems:

  • In transfection systems with high receptor expression, activation of a small population of receptor molecules can result in a maximal cAMP response

  • This may cause small differences in binding affinities to result in larger differences in potencies to activate second messenger cascades

  • Researchers should consider that binding affinities may be stronger indicators of potency in natural systems with fewer receptors

Assay Selection and Standardization:

  • Binding assays may show different results than functional assays (cAMP production)

  • Using both types of assays provides complementary information about receptor-ligand interactions

  • The Bmax values for all receptors should be compared to ensure similar expression levels across experimental conditions (typical values are approximately 2.4 ± 0.4 pmol/mg of membrane protein)

How does CRH function during metamorphosis in Xenopus laevis?

Metamorphosis in Xenopus laevis involves complex hormonal regulation, with CRH playing several important roles:

Pre-metamorphic Role:

  • Before transformation, CRH acts as a cytoprotective agent in the tadpole tail

  • CRH, acting via the CRF1 receptor, slows spontaneous tail regression in explant culture

  • CRH causes a reduction in caspase 3/7 activity, indicating an anti-apoptotic effect

During Metamorphosis:

  • Amphibian tadpoles lose their tails through programmed cell death induced by thyroid hormone (T3)

  • CRH-BP is strongly upregulated in the tail during spontaneous or T3-induced metamorphosis

  • This upregulation suggests a role in modulating CRH activity during this critical developmental transition

Regulation of Cell Death:

  • Overexpression of CRH-BP in vivo accelerates the loss of tail muscle cells during spontaneous metamorphosis

  • This suggests that the balance between CRH and CRH-BP is crucial for appropriate regulation of cell death during metamorphosis

  • CRH likely provides a protective function that is antagonized by increased CRH-BP expression

How does environmental stress modulate CRH expression and function in Xenopus laevis?

Environmental stress significantly impacts CRH expression and function in Xenopus laevis through several mechanisms:

Response to Hypoxia:

  • Exposure of tail explants to hypoxia increases CRH and urocortin 1 mRNA expression

  • Hypoxia strongly decreases CRH-BP mRNA expression

  • This modulation likely increases free CRH availability and enhances CRH signaling under stress conditions

Regulatory Mechanism:

  • The inhibitory binding protein for CRH (CRH-BP) is regulated by both hormones and environmental stressors

  • This regulation provides a mechanism to modulate CRH bioactivity in response to changing environmental conditions

  • The balance between CRH and CRH-BP appears crucial for appropriate stress responses

Cytoprotective Effects:

  • CRH is upregulated by environmental stressors and provides cytoprotective effects

  • CRH causes a reduction in caspase 3/7 activity, suggesting an anti-apoptotic function during stress

  • CRH increases [³H]thymidine incorporation, indicating promotion of cell proliferation in response to stress

This complex regulation allows for adaptive responses to environmental challenges while maintaining developmental trajectories.

What are the interrelationships between CRH and other hormonal systems in Xenopus?

While the search results focus primarily on CRH, there is information about interactions with other hormonal systems in Xenopus:

Thyroid Hormone System:

  • Thyroid hormone (T3) induces programmed cell death in tadpole tail during metamorphosis

  • CRH-BP is strongly upregulated in the tail during T3-induced metamorphosis

  • This suggests cross-talk between the thyroid hormone and CRH signaling pathways

Leptin System:

  • Like CRH, leptin is a hormone with developmental roles in Xenopus

  • While CRH plays roles in tail resorption and stress responses, leptin appears more involved in limb development and later in appetite regulation

  • Both hormones likely interact with thyroid hormone signaling during metamorphosis

  • Recombinant Xenopus leptin (rxLeptin) becomes a potent anorexigen in frogs, but this response does not develop until midprometamorphosis, suggesting developmental regulation of hormone sensitivity

Stress Response System:

  • CRH is a key component of the stress response system

  • The regulation of CRH and CRH-BP by environmental stressors suggests integration with broader stress response mechanisms

  • The CRH system likely interacts with the hypothalamic-pituitary-adrenal (HPA) axis in amphibians as it does in mammals

How can researchers effectively design experiments to investigate the evolutionary conservation of CRH function between amphibians and mammals?

To effectively design experiments investigating evolutionary conservation of CRH function between amphibians and mammals, researchers should consider:

Comparative Receptor Pharmacology:

  • Test mammalian CRH ligands on Xenopus receptors and vice versa

  • Use standardized assays (binding affinity, cAMP production) across species

  • Compare dose-response curves and EC₅₀ values systematically

  • Create chimeric receptors between species to identify domains responsible for species-specific responses

Comparative Sequence and Structure Analysis:

  • Align CRH, CRH-BP, and CRH receptor sequences across species to identify conserved domains

  • Use protein modeling to compare predicted tertiary structures despite low primary sequence homology

  • Focus on functionally important regions identified through mutagenesis studies, such as the five key amino acids in Xenopus CRF-R1

Developmental Studies:

  • Compare the ontogeny of CRH system expression and function across species

  • Investigate the role of CRH in conserved developmental processes

  • Examine how the CRH system interacts with other conserved hormonal systems (thyroid hormone, glucocorticoids)

Stress Response Experiments:

  • Subject both amphibian and mammalian models to comparable stressors

  • Measure CRH system components (peptide levels, receptor expression, downstream signaling)

  • Compare physiological and behavioral responses to CRH administration

What are the key differences in CRH receptor pharmacology between Xenopus and mammalian species?

Significant pharmacological differences exist between Xenopus and mammalian CRH receptors:

Ligand Selectivity:

  • Mammalian CRF-R1 is relatively non-selective for different CRF ligands (CRF from different species, urocortin, urotensin I, and sauvagine)

  • Xenopus CRF-R1 shows remarkable ligand selectivity, with 10-22 fold higher affinity for urotensin I, urocortin, human/rat CRF, and Xenopus CRF compared to ovine CRF and sauvagine

Binding Affinities:
Comparative binding affinities (Kd values) for Xenopus CRF-R1:

  • High affinity for h/rCRF, xCRF, urotensin I, and urocortin

  • Low affinity for ovine CRF (31.7 nM) and sauvagine (51.4 nM)

Functional Potency:

  • EC₅₀ values in cAMP assays: 39.7 nM for sauvagine vs. 1.1 nM for human/rat CRF or Xenopus CRF

  • This contrasts with mammalian CRF-R1, where these ligands have similar potencies

Structural Basis:

  • The ligand selectivity of Xenopus CRF-R1 is determined by five specific amino acids in the N-terminal extracellular domain (positions 76, 81, 83, 88, and 89)

  • Mutation of these residues in human CRF-R1 to the corresponding Xenopus residues created a ligand-selective receptor, demonstrating the critical role of these specific amino acids

These pharmacological differences provide valuable insights into receptor-ligand interactions and may reflect evolutionary adaptations to different physiological requirements.

What are optimal expression systems for producing recombinant Xenopus CRH?

Based on the methodologies described in the research literature, several expression systems have been successfully employed:

Mammalian Cell Expression:

  • Human Embryonic Kidney 293 (HEK 293) cells have been successfully used for expression of recombinant CRH receptors and could be adapted for CRH production

  • These cells provide appropriate post-translational modifications for proper protein folding

Quality Control Methods:

  • Verification of activity through radioreceptor binding assays

  • Functional verification through cAMP assays in HEK 293 cells expressing CRH receptors

  • Scatchard analysis to determine binding affinity (Kd) and receptor density (Bmax)

Analytical Confirmation:

  • Mass spectrometry to confirm molecular weight

  • Amino acid sequencing to verify the correct primary structure

For functional testing of recombinant CRH or related peptides, researchers have employed:

  • Membrane preparations from permanently transfected HEK 293 cells expressing various CRH receptors

  • Binding assays with 50-100 μg of protein

  • cAMP assays with cells plated at 10⁵ cells per well in 24-well dishes

What challenges exist in producing biologically active recombinant Xenopus CRH for research applications?

Several challenges must be addressed when producing biologically active recombinant Xenopus CRH:

Structural Integrity:

  • Ensuring proper folding of the peptide is critical for biological activity

  • The tertiary structure must be maintained through appropriate disulfide bond formation

Ligand Selectivity Testing:

  • Due to the unique ligand selectivity of Xenopus CRH receptors, biological activity testing requires specific considerations

  • Activity should be confirmed using both Xenopus and mammalian receptor systems for comparative analysis

Temperature Considerations:

  • Xenopus is normally maintained at room temperature, while mammalian cells are typically cultured at 37°C

  • These temperature differences may affect receptor folding and ligand-receptor interactions in testing systems

Experimental Design:

  • When testing recombinant Xenopus CRH, researchers should consider that:

    • Different CRH analogs may have different stability in experimental conditions

    • Receptor expression levels in test systems can affect apparent potency

    • Both binding and functional assays should be performed for comprehensive characterization

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.